APO Research
Talk to an analyst

APO RESEARCH · REPORT

Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025184 pages

Choose your research edition.

Industry ResearchRecombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine include Johnson & Johnson, Merck & Co., Inc., Pfizer Inc., GlaxoSmithKline Plc, Serum Institute of India, Sanofi Pasteur, Emergent Biosolutions and CSL Limited, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Segment by Company

Johnson & Johnson

Merck & Co., Inc.

Pfizer Inc.

GlaxoSmithKline Plc

Serum Institute of India

Sanofi Pasteur

Emergent Biosolutions

CSL Limited

Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Segment by Type

Pediatric Hepatitis B (CHO) Vaccine

Adult Hepatitis B (CHO) Vaccine

Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Segment by Application

Hospitals

Clinics

Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Industry Trends Table 2. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Industry Drivers Table 3. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Industry Opportunities and Challenges Table 4. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Industry Restraints Table 5. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Manufacturers (doses) & (2021-2026) Table 8. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Manufacturers Table 9. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Average Sales Price (US$/dose) of Manufacturers (2021-2026) Table 10. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Manufacturers, Product Type & Application Table 13. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Pediatric Hepatitis B (CHO) Vaccine Table 17. Major Manufacturers of Adult Hepatitis B (CHO) Vaccine Table 18. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type 2021 VS 2025 VS 2032 (doses) Table 19. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2021-2026) & (doses) Table 20. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2027-2032) & (doses) Table 21. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Type (2021-2026) Table 22. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Type (2027-2032) Table 23. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Type 2021 VS 2025 VS 2032 (doses) Table 24. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Type (2021-2026) & (doses) Table 25. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Type (2027-2032) & (doses) Table 26. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Type (2021-2026) Table 27. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospitals Table 29. Major Manufacturers of Clinics Table 30. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application 2021 VS 2025 VS 2032 (doses) Table 31. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2021-2026) & (doses) Table 32. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2027-2032) & (doses) Table 33. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Application (2021-2026) Table 34. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Application (2027-2032) Table 35. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Application 2021 VS 2025 VS 2032 (doses) Table 36. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Application (2021-2026) & (doses) Table 37. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Application (2027-2032) & (doses) Table 38. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Application (2021-2026) Table 39. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Application (2027-2032) Table 40. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Region: 2021 VS 2025 VS 2032 (doses) Table 41. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Region (2021-2026) & (doses) Table 42. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Region (2021-2026) Table 43. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Forecasted by Region (2027-2032) & (doses) Table 44. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (doses) Table 46. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2021-2026) & (doses) Table 47. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2027-2032) & (doses) Table 48. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (doses) Table 49. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2021-2026) & (doses) Table 50. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2027-2032) & (doses) Table 51. Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (doses) Table 52. Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2021-2026) & (doses) Table 53. Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2027-2032) & (doses) Table 54. South America, Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (doses) Table 55. South America, Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2021-2026) & (doses) Table 56. South America, Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2027-2032) & (doses) Table 57. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Region (2021-2026) Table 61. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Region (2027-2032) Table 62. Johnson & Johnson Company Information Table 63. Johnson & Johnson Business Overview Table 64. Johnson & Johnson Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (doses), Price (US$/dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Johnson & Johnson Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio Table 66. Johnson & Johnson Recent Development Table 67. Merck & Co., Inc. Company Information Table 68. Merck & Co., Inc. Business Overview Table 69. Merck & Co., Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (doses), Price (US$/dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Merck & Co., Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio Table 71. Merck & Co., Inc. Recent Development Table 72. Pfizer Inc. Company Information Table 73. Pfizer Inc. Business Overview Table 74. Pfizer Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (doses), Price (US$/dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Pfizer Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio Table 76. Pfizer Inc. Recent Development Table 77. GlaxoSmithKline Plc Company Information Table 78. GlaxoSmithKline Plc Business Overview Table 79. GlaxoSmithKline Plc Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (doses), Price (US$/dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. GlaxoSmithKline Plc Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio Table 81. GlaxoSmithKline Plc Recent Development Table 82. Serum Institute of India Company Information Table 83. Serum Institute of India Business Overview Table 84. Serum Institute of India Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (doses), Price (US$/dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Serum Institute of India Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio Table 86. Serum Institute of India Recent Development Table 87. Sanofi Pasteur Company Information Table 88. Sanofi Pasteur Business Overview Table 89. Sanofi Pasteur Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (doses), Price (US$/dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Sanofi Pasteur Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio Table 91. Sanofi Pasteur Recent Development Table 92. Emergent Biosolutions Company Information Table 93. Emergent Biosolutions Business Overview Table 94. Emergent Biosolutions Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (doses), Price (US$/dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Emergent Biosolutions Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio Table 96. Emergent Biosolutions Recent Development Table 97. CSL Limited Company Information Table 98. CSL Limited Business Overview Table 99. CSL Limited Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (doses), Price (US$/dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. CSL Limited Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio Table 101. CSL Limited Recent Development Table 102. Key Raw Materials Table 103. Raw Materials Key Suppliers Table 104. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Distributors List Table 105. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Customers List Table 106. Research Programs/Design for This Report Table 107. Authors List of This Report Table 108. Secondary Sources Table 109. Primary Sources List of Figures Figure 1. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Image Figure 2. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (2021-2032) & (doses) Figure 5. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Average Price (US$/dose) & (2021-2032) Figure 6. Global Top 5 and 10 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Pediatric Hepatitis B (CHO) Vaccine Image Figure 9. Adult Hepatitis B (CHO) Vaccine Image Figure 10. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2021 VS 2025 VS 2032) & (doses) Figure 11. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Type (2021-2032) Figure 13. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (doses) Figure 14. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Type (2021-2032) Figure 16. Hospitals Image Figure 17. Clinics Image Figure 18. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2021 VS 2025 VS 2032) & (doses) Figure 19. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Application (2021-2032) Figure 21. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (doses) Figure 22. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Application (2021-2032) Figure 24. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Growth Rate (2021-2032) & (doses) Figure 25. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Country (2021-2032) Figure 26. U.S. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Growth Rate (2021-2032) & (doses) Figure 27. Canada Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Growth Rate (2021-2032) & (doses) Figure 28. Mexico Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Growth Rate (2021-2032) & (doses) Figure 29. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Growth Rate (2021-2032) & (doses) Figure 30. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Country (2021-2032) Figure 31. Germany Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Growth Rate (2021-2032) & (doses) Figure 32. France Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Growth Rate (2021-2032) & (doses) Figure 33. U.K. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Growth Rate (2021-2032) & (doses) Figure 34. Italy Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Growth Rate (2021-2032) & (doses) Figure 35. Netherlands Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Growth Rate (2021-2032) & (doses) Figure 36. Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Growth Rate (2021-2032) & (doses) Figure 37. Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Country (2021-2032) Figure 38. China Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Growth Rate (2021-2032) & (doses) Figure 39. Japan Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Growth Rate (2021-2032) & (doses) Figure 40. South Korea Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Growth Rate (2021-2032) & (doses) Figure 41. Southeast Asia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Growth Rate (2021-2032) & (doses) Figure 42. India Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Growth Rate (2021-2032) & (doses) Figure 43. Australia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Growth Rate (2021-2032) & (doses) Figure 44. South America, Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Growth Rate (2021-2032) & (doses) Figure 45. South America, Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Country (2021-2032) Figure 46. Brazil Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Growth Rate (2021-2032) & (doses) Figure 47. South Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Growth Rate (2021-2032) & (doses) Figure 48. Saudi Arabia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Growth Rate (2021-2032) & (doses) Figure 49. Turkey Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Growth Rate (2021-2032) & (doses) Figure 50. Argentina Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Growth Rate (2021-2032) & (doses) Figure 51. UAE Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Growth Rate (2021-2032) & (doses) Figure 52. Egypt Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Growth Rate (2021-2032) & (doses) Figure 53. Chile Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Growth Rate (2021-2032) & (doses) Figure 54. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue (2021-2032) & (US$ Million) Figure 57. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue (2021-2032) & (US$ Million) Figure 59. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Pediatric Hepatitis B (CHO) Vaccine
  • Adult Hepatitis B (CHO) Vaccine
Applications
  • Hospitals
  • Clinics
Companies covered
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Pfizer Inc.
  • GlaxoSmithKline Plc
  • Serum Institute of India
  • Sanofi Pasteur
  • Emergent Biosolutions
  • CSL Limited

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Dynamics
  1. 2.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Industry Trends
  2. 2.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Industry Drivers
  3. 2.3 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Industry Opportunities and Challenges
  4. 2.4 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Industry Restraints
3 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market by Manufacturers
  1. 3.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Tier 1, Tier 2, and Tier 3
4 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market by Type
  1. 4.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Type Introduction
  2. 4.1.1 Pediatric Hepatitis B (CHO) Vaccine
  3. 4.1.2 Adult Hepatitis B (CHO) Vaccine
  4. 4.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type
  5. 4.2.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2021-2032)
  7. 4.2.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Type (2021-2032)
  8. 4.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Type
  9. 4.3.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Type (2021-2032)
  11. 4.3.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Type (2021-2032)
5 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market by Application
  1. 5.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application
  5. 5.2.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2021-2032)
  7. 5.2.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Application (2021-2032)
  8. 5.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Application
  9. 5.3.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Application (2021-2032)
  11. 5.3.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Application (2021-2032)
6 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Region
  1. 6.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Region
  1. 7.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Region
  2. 7.1.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue (2021-2032)
  8. 7.2.2 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Johnson & Johnson
  2. 8.1.1 Johnson & Johnson Company Information
  3. 8.1.2 Johnson & Johnson Business Overview
  4. 8.1.3 Johnson & Johnson Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Johnson & Johnson Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio
  6. 8.1.5 Johnson & Johnson Recent Developments
  7. 8.2 Merck & Co., Inc.
  8. 8.2.1 Merck & Co., Inc. Company Information
  9. 8.2.2 Merck & Co., Inc. Business Overview
  10. 8.2.3 Merck & Co., Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Merck & Co., Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio
  12. 8.2.5 Merck & Co., Inc. Recent Developments
  13. 8.3 Pfizer Inc.
  14. 8.3.1 Pfizer Inc. Company Information
  15. 8.3.2 Pfizer Inc. Business Overview
  16. 8.3.3 Pfizer Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio
  18. 8.3.5 Pfizer Inc. Recent Developments
  19. 8.4 GlaxoSmithKline Plc
  20. 8.4.1 GlaxoSmithKline Plc Company Information
  21. 8.4.2 GlaxoSmithKline Plc Business Overview
  22. 8.4.3 GlaxoSmithKline Plc Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 GlaxoSmithKline Plc Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio
  24. 8.4.5 GlaxoSmithKline Plc Recent Developments
  25. 8.5 Serum Institute of India
  26. 8.5.1 Serum Institute of India Company Information
  27. 8.5.2 Serum Institute of India Business Overview
  28. 8.5.3 Serum Institute of India Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Serum Institute of India Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio
  30. 8.5.5 Serum Institute of India Recent Developments
  31. 8.6 Sanofi Pasteur
  32. 8.6.1 Sanofi Pasteur Company Information
  33. 8.6.2 Sanofi Pasteur Business Overview
  34. 8.6.3 Sanofi Pasteur Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sanofi Pasteur Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio
  36. 8.6.5 Sanofi Pasteur Recent Developments
  37. 8.7 Emergent Biosolutions
  38. 8.7.1 Emergent Biosolutions Company Information
  39. 8.7.2 Emergent Biosolutions Business Overview
  40. 8.7.3 Emergent Biosolutions Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Emergent Biosolutions Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio
  42. 8.7.5 Emergent Biosolutions Recent Developments
  43. 8.8 CSL Limited
  44. 8.8.1 CSL Limited Company Information
  45. 8.8.2 CSL Limited Business Overview
  46. 8.8.3 CSL Limited Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 CSL Limited Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio
  48. 8.8.5 CSL Limited Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Value Chain Analysis
  2. 9.1.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Mode & Process
  6. 9.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Distributors
  9. 9.2.3 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst